全文获取类型
收费全文 | 25473篇 |
免费 | 1836篇 |
国内免费 | 335篇 |
专业分类
耳鼻咽喉 | 71篇 |
儿科学 | 204篇 |
妇产科学 | 151篇 |
基础医学 | 1071篇 |
口腔科学 | 727篇 |
临床医学 | 3460篇 |
内科学 | 1818篇 |
皮肤病学 | 278篇 |
神经病学 | 685篇 |
特种医学 | 857篇 |
外国民族医学 | 1篇 |
外科学 | 1360篇 |
综合类 | 5106篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 9295篇 |
眼科学 | 181篇 |
药学 | 1442篇 |
53篇 | |
中国医学 | 426篇 |
肿瘤学 | 453篇 |
出版年
2024年 | 76篇 |
2023年 | 474篇 |
2022年 | 737篇 |
2021年 | 994篇 |
2020年 | 1203篇 |
2019年 | 763篇 |
2018年 | 721篇 |
2017年 | 765篇 |
2016年 | 766篇 |
2015年 | 854篇 |
2014年 | 2125篇 |
2013年 | 2036篇 |
2012年 | 2137篇 |
2011年 | 2060篇 |
2010年 | 1616篇 |
2009年 | 1420篇 |
2008年 | 1501篇 |
2007年 | 1294篇 |
2006年 | 1142篇 |
2005年 | 901篇 |
2004年 | 765篇 |
2003年 | 677篇 |
2002年 | 439篇 |
2001年 | 401篇 |
2000年 | 302篇 |
1999年 | 187篇 |
1998年 | 181篇 |
1997年 | 171篇 |
1996年 | 140篇 |
1995年 | 126篇 |
1994年 | 90篇 |
1993年 | 68篇 |
1992年 | 69篇 |
1991年 | 86篇 |
1990年 | 61篇 |
1989年 | 29篇 |
1988年 | 38篇 |
1987年 | 31篇 |
1986年 | 19篇 |
1985年 | 41篇 |
1984年 | 33篇 |
1983年 | 15篇 |
1982年 | 13篇 |
1981年 | 16篇 |
1980年 | 18篇 |
1979年 | 10篇 |
1978年 | 8篇 |
1976年 | 9篇 |
1974年 | 3篇 |
1973年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
社会力量具备相应的经济基础和技术条件,对于公立互联网医院体系建设具有积极的促进作用。但是实践中仍然存在商业模式不完善、监管制度不健全等问题。基于经济学契约理论要义,提出在坚持激励与约束机制并举、平衡公私益关系的前提下,通过完善医保政策、构建互联网医疗服务价格分类管理机制来促进社会力量向医疗服务公益性目标回归,并通过构建完善的监督体制来约束部分社会力量的盲目逐利性行为。 相似文献
2.
3.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
4.
《The Journal for Nurse Practitioners》2022,18(2):232-235
The coronavirus disease 2019 pandemic disrupted health care, requiring organizational leaders to act quickly to manage the health-related concerns of individuals and communities. The ability to offer a variety of digitally enabled telehealth services with 24/7 access to nurse practitioners and physician assistants allowed us to care for patients in their homes. It reduced the spread of the virus, protected our employees from further disease spread, and provided early interventions to those in need. The roles of nurse practitioner leaders, the enacted strategies, and patient outcomes demonstrate the impact of an innovative digital care delivery model on care across the continuum. 相似文献
5.
6.
7.
8.
Biodegradable Polydioxanone Microspheres for Transcatheter Arterial Embolization: Proof of Principle
《Journal of vascular and interventional radiology : JVIR》2020,31(12):2132-2140.e5
PurposeTo evaluate feasibility, embolization success, biodegradability, reperfusion, and biocompatibility of biodegradable microspheres (MS) made from polydioxanone (PDO) for transcatheter arterial embolization.Materials and MethodsUnilateral selective renal embolization of a segmental artery was performed in 16 New Zealand White rabbits with PDO-MS (100–150 μm and 90–315 μm). Animals were randomly assigned to different observation periods and underwent control digital subtraction angiography (DSA) and MR imaging immediately (n = 3), 1 week (n = 2), 4 weeks (n = 2), 8 weeks (n = 2), 12 weeks (n = 5), and 16 weeks (n = 2) after embolization. Kidneys were harvested for macroscopic and histologic analysis of embolization success, biodegradability, and biocompatibility.ResultsEmbolization was technically successful in 15 of 16 animals. One animal died of anesthesia-related circulatory failure. The 100–150 μm MS were injected easily through 3-F catheters; the 90–315 μm MS tended to clog with intermittent catheter obstruction. DSA and MR imaging showed successful target embolization in 13 of 15 animals. In 2 animals, the entire kidney was affected owing to catheter clogging, including a reflux of MS while flushing. Control DSA and MR imaging showed increasing vascular reperfusion with time. Macroscopic and histologic analysis revealed necrosis/infarction in areas in which embolization was achieved. MS were extensively degraded after 16 weeks, and overall inflammatory reaction was mild.ConclusionsBiodegradable PDO-MS induced effective embolization of target vessels while demonstrating good biocompatibility. MS increasingly dissolved at 16 weeks, partial reperfusion started at week 1, and complete reperfusion started at week 8, thus offering possible advantages as a temporary embolic agent. 相似文献
9.
10.
《Journal of vascular and interventional radiology : JVIR》2020,31(6):986-992
PurposeTo assess the feasibility, safety, and efficacy of balloon-assisted delivery of ethylene vinyl alcohol copolymer (EVOH) for a range of peripheral arterial applications.Materials and MethodsSix academic medical centers entered retrospective data on 46 consecutive patients (27 men, 19 women; ages, 11–94 y; mean age, 50.3 y) who underwent 60 balloon-assisted EVOH procedures. The cohort was restricted to procedures involving peripheral, nonneural arteries 1–5.5 mm in diameter. Clinical indications included a wide range of vascular pathologic conditions (most commonly arteriovenous malformations [n = 20], renal angiomyolipomas [n = 8], and acute hemorrhage [n = 9]) and targeted visceral and musculoskeletal peripheral arteries. Data collected included sex, age, clinical indication, arterial pathology, arteries embolized, type of occlusion balloon microcatheter, type and concentration of EVOH agent, effectiveness as an embolic backstop, vessels protected, adequacy of EVOH cast penetration, catheter extraction, nontarget embolization, and complications.ResultsBalloon occlusion prevented EVOH reflux in 59 of 60 procedures (98.3%). Nontarget EVOH embolization occurred in 2 procedures (3.3%). Adequate EVOH cast penetration and complete filling of the target pathologic structure were seen in 57 of 60 procedures (95%). Balloon deflation and uneventful extraction occurred in all procedures; small EVOH fragments detached into target arteries in 2 cases. One major (1.7%) and 2 minor (3.3%) complications occurred.ConclusionsBalloon-assisted EVOH embolization of peripheral arteries is feasible, safe, effective, and versatile. The primary advantage of balloon-assisted EVOH embolization is the ability to apply more injection pressure to advance the EVOH cast assertively into the pathologic structure(s). 相似文献